New Delhi, March 1 (IANS) The developer of Covid-19 vaccine Covaxin, Bharat Biotech is considering an initial public offering that could raise over $500 million, according to sources cited by multiple reports.Discussions are underway including key aspects of the proposed share sale, including size and timing, they said.Bharat Biotech plans Rs 200–250 crore of capital expenditure in FY26 for a large vaccine manufacturing facility being developed under Sapigen Biologix Pvt Ltd in Bhubaneswar, Od…
Trending
- Vada Pappu for Narasimha Jayanti – The Sacred No-Cook Moong Dal Prasadam That Asks Almost Nothing of You
- Neer Mor Recipe — The Chilled Spiced Buttermilk That Completes the Narasimha Jayanti Thali
- Phula (2026) Movie Review: A Soulful Tale of Resilience and Folk Art
- Therachaapa Movie Review: A Rooted Rustic Drama Packed With Emotion and Grit
- Salbardi (2026) Review: A Gripping Tale of Mystery and Justice From the Heartland
- Bad Boy Karthik Review (2026): A Brother’s Fight That Packs Enough Heart to Win You Over
- Matka King Review: Vijay Varma’s Finest Hour in a Gripping Bombay Crime Drama
- Pallichattambi Movie Review: Tovino Thomas Leads a Powerful Period Drama with Mass Appeal